SEC Form 4 · accession 0001140361-15-023272
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heiner Dreismann
Director
Period of report
Jun 3, 2015
Accepted (ET)
Jun 4, 2015 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 3, 2015 | A | 34,091 | $1.32 | A | 50,177 | D | |
| Common StockF1 | holding | — | — | — | 16,086 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock units that vest one-third on each of August 13, 2015, August 13, 2016, and August 13, 2017.
- F2On June 3, 2015, the date of the Company's annual meeting of stockholders, Mr. Dreismann was granted 34,091 restricted stock units, of which 11,363 vest on June 3, 2016 and 11,364 vest on each of June 3, 2017 and June 3, 2018.